Oxford Metrics already on course for full year forecast

0

At its AGM, Oxford Metrics (LON: OMG) said its current order book and near-term pipeline opportunities fully underpin the 2022-23 forecast revenues of £36.9m, up from £28.8m last year. Sales are expected to be second half weighted.

There is strong demand for the Vicon motion capture technology. The timing of orders could affect the full year outcome, but there is also plenty of upside from potential additional business. Supply chain problems are easing, which means that this should not hamper progress this year.

Pre-tax profit is forecast to rise from £2.6m to £5.9m. Net cash is forecast to be £66.7m at the end of September 2023. That is due to last year’s sale of Yotta to Causeway Technologies for £52m.

The share price rose 5.77% to 110p, valuing AIM-quoted Oxford Metrics at £135.4m. The prospective multiple is 27, but the cash pile is only expected to earn a few hundred thousand pounds. Given the strong performance from Vicon, the underlying business appears undervalued.

British American Tobacco shares fall despite new category confidence

British American Tobacco share were weaker on Thursday despite strength in their New Categories unit and a 6% dividend hike.

Total group revenue rise 7.7% to £27.6bn in 2022 and operating profit grew 2.8% to £10.5bn.

The group said they were confident their vapes and no-tobacco business would hit £5bn by 2025 as volume growth continued. However, it was weakness in their traditional combustibles core business causing concern with sluggish growth and further contraction of the market predicted.

“It’s hard to tell how much of this came from smokers feeling the squeeze of rising prices, and how much came from a drive by smokers to become more healthy,” said Derren Nathan, head of equity research at Hargreaves Lansdown.

“BATS’ cigarette brands include the likes of Rothmans, Camel and Newport. Despite the significant fall in volume of its biggest sales category, profits have done well. This has been helped by cost savings and strong pricing.”

Cash generated from operating activities grew 7% in the period and BATS said they were hiking their dividend by 6%.

“Another year of 100% cash conversion underpins the 8% dividend yield as well as investment in new categories but we note the statement of intent around debt repayment, with improved balance sheet strength now a priority. In the short term we see further approvals of US pre-market tobacco product applications (PMTAs) for new categories as pivotal to investor sentiment,” Nathan said.

AIM movers: Genedrive test approval and ex-dividends

0

Genedrive (LON: GDR) has received preliminary approval from the National Institute of Clinical Excellence (NICE) for its antibiotic-induced hearing loss (AIHL) genetic test. NICE concluded that the test can identify babies at risk of hearing loss if given certain antibiotics. The NHS can use the test following this approval, which should be ratified on 21 February. Before trading commenced this morning, finnCap said that this is “unlikely to be a major value driver for Genedrive or for the shares in the short-term”. There has been publicity about this news and that has helped to push up the share price by 35% to 33.75p.

Shield Therapeutics (LON: STX) revenues were slightly lower than forecast. The share price recovered 14.6% to 7.05p. Investor appear to be looking ahead to the possibilities for iron deficiency treatment Accrufer in the US following the signing of the joint venture with Viatris.

Fusion Antibodies (LON: FAB) has launched a new service for high volume mammalian cell surface expression and screening of antibodies called Mammalian Display. This comes out of the OptiMAL research programme. The share price is 5.56% higher at 47.5p.

In 2022, transport information systems supplier Journeo (LON: JNEO) increased revenues by 35% to £21.1m. The order intake increased by 50% to £27m. The number of vehicles connected to Journeo’s platform jumped by 150% to 10,000. The acquisition of Infotec was completed on 18 January. The share price rose 3.89% to 133.5p.

Touch sensors manufacture Zytronic (LON: ZYT) is being affected by continuing global supply chain issues. This has increased costs and wage negotiations have commenced which will lead to a further rise in costs in the second half. There are opportunities with a projected lifetime value of £61m. Net cash was £6.8m at the end of January. Mark Cambridge will concentrate on his chief executive role, and he will be replaced as chair by Mark Butcher. John Walter, the largest individual shareholder, is joining the board until the 2024 AGM. The shares have also gone ex-dividend – 2.2p a share. The share price slumped 15% to 127.5p.

Beowulf Mining (LON: BEM) has launched the Swedish Depositary Receipts rights issue and Primary Bid offer at 2.06p a share. It is raising up to £9.1m to finance the development of the Kallak iron mine. The cash will fund a pre-feasibility study and resource drilling, as well as reducing debt. The share price fell 11.8% to 2.875p.

Strategic Materials (LON: SML) was hit by lower sales volumes from the Cobre magnetite tailings operation in the fourth quarter. There were lower sales to cement customers in the US. A 20% price increase in July helped offset this so fourth quarter revenues so fourth quarter revenues were $464,000, down from $493,000 in the fourth quarter of 2021. There was $341,000 in cash at the end of 2022. Funding negotiations for restarting production at the Leigh Creek copper mine are at an advanced stage. The share price declined by 7.69% to 0.3p

TPXimpact (LON: TPX) executive director Michael Dearing has transferred a 1.61% stake in the digital transformation company to his former spouse following their divorce. He still owns 2.08%, but it is uncertain whether the shares transferred will be held for the long-term. The share price slipped 4.55% to 21p.

Ex-dividends

Impax Asset Management (LON: IPX) is paying a final dividend of 22.9p a share and the share price declined by 31.5p to 846.5p.

Renew Holdings (LON: RNWH) is paying a final dividend of 11.33p a share and the share price rose 8.5p to 734.5p.

Titon (LON: TON) is paying a final dividend of 0.5p a share and the share price is unchanged at 70p.

Victorian Plumbing (LON: VIC) is paying a final dividend of 1.1p a share and the share price fell by 2.8p to 90.2p.

Zytronic (LON: ZYT) is paying a final dividend of 2.2p a share and the share price slumped 22.5p to 127.5p.

AdEPT Technology agrees bid from better-funded rival

Managed IT and networking services provider AdEPT Technology (LON: ADT) is being snapped up by a private equity backed Wavenet, which provides telecom services. The high level of debt has held back the AdEPT Technology share price in the past couple of years and although the 201p a share bid is a 75% premium to the previous market price it is still well below past levels. The share price was more than 300p less than two years ago and was double the offer price in 2018.
However, shareholders will not get the 2.5p a share interim dividend. The bid values the AIM-quoted company at £50.3m. Net deb...

Songtradr snaps up music streaming technology company 7digital

0

Songtradr Inc has launched an agreed bid for AIM-quoted music streaming technology developer 7digital Group (LON: 7DIG) and the 0.695p a share offer values the company at £19.4m. The share price has not been at this level since September 2021.

Songtradr is a music licensing company with a platform and technology that connects music rights holders to brands and content creators. Combining the businesses will simplify licensing and potentially accelerate growth. Video games and other digital demand for music is expanding.

Songtradr has raised more than $100m and it has the financial clout and scale to take full advantage of the 7digital technology. In September 2020, 7digital raised £6m at 2.25p a share and that cash has been used up. Previous fundraisings have been done at much higher share prices.

In the six months to June 2022, revenues grew by 21% to £3.9m, with licensing revenues jumping to £2.5m. The company is still losing money but moving towards breakeven. Cash was running out and a £500,000 loan was obtained from 27.3% shareholder Magic Investments, taking the total owed to £1m.

Songtradr will pay back the Magic Investments loan and a £2m loan facility from Investec.

7digital has a radio production business and it is unclear if this will fit in with the enlarged group strategy. It was generating cash for 7digital.

F3 Uranium shares jump on promising drill results

F3 Uranium’s drill campaign at the Patterson Lake North (PLN) project has produced further promising mineralisation encounters that build on bumper uranium grades discovered in December.

Having confirmed the discovery of uranium with grades up to 59.2% U3O8 in December, F3 have drilled 8 of 20 holes planned for their winter drill programme to further map deposits at PLN’s JR Zone.

Today’s announcement further confirms the prospectiveness of the PLN project and F3 Uranium shares jumped 10% to C$0.34 on Wednesday.

There was a standout hole, PLN23-048, which yielded 14m total composite mineralisation from 246.5m – 260.5m with high levels of radioactivity.

“The drill program started by testing the depth extent of the zone, while also testing it along strike from the discovery area on line 00N,” said Raymond Ashley, Vice President Exploration at F3 Uranium.

“The team is becoming familiar with the geology and controls on mineralization on the JR Zone which is currently defined over an area measuring approximately 45m by 50m and have identified strong continuity of high grade mineralization along strike towards the south as the program continues to explore that direction to increase the total mineralized strike length. Additionally, we are continuing to drill test further towards the unconformity, with the objective to test the intersection of the A1 main shear zone at the unconformity.”

FTSE 100 breaks to all-time highs on growth optimism

The FTSE 100 once again broke to all-time highs on Wednesday as optimism around UK economic growth boosted sentiment in UK stocks.

The index was also support by another strong session from BP after their shares received an ambitious 1,000p price target from analysts at Barclays. BP shares were 3% at the time of writing on Wednesday.

General sentiment improved on Wednesday after the National Institute of Economic and Social Research (Niesr) Think Tank said they expected the UK economy to avoid recession.

The Think Tank’s prediction is at odds with the Bank of England’s forecast of a recession – although the bank have recently improved their outlook from a prolonged downturn, to a short and shallow contraction.

“The tide of optimism washing over the London market is being pushed higher with the latest economic assessment judging that the UK could avoid a recession,” said Susannah Streeter, senior investment and markets analyst Hargreaves Lansdown.

With the outlook for the UK economy improving in most quarters, the FTSE 100 was helped 0.6% higher to 7,919. The index had hit 7,933 earlier in the session – a fresh intraday all-time FTSE 100 high.

UK domestic stocks

While BP was doing a lot of the heavy lifting on Wednesday, the FTSE 100’s UK-focused stocks provided support for the index after the more optimistic UK economic prediction.

Housebuilders and retailers were among the top risers.

The homebuilding sector was spurred on by an upbeat release from Barratt Developments. Barrett’s said although forward sales were considerably lower than this time last year, they had seen signs of a revival in January.

“While the outlook for the second half of Barratt’s financial year remains uncertain, we’re cautiously optimistic for the group’s prospects in the long run. Recession fears have put housebuilders in a tricky spot, but Barratt’s significant net cash position of £965m gives it plenty of breathing room, even if the housing market deteriorates further,” said Aarin Chiekrie, equity analyst at Hargreaves Lansdown.

Barratt’s shares rose 2.2% but it was Persimmon, storming ahead by 3.2%, that was the FTSE 100’s top riser at the time of writing. Persimmon will release final results 1st March.

Fraser Group’s consumers will enjoy a healthier UK economy and investors bid their shares up by 3% to 808p. The same sentiment was shared by Next with the bellwether retailer adding 2.8%.

AIM movers: URU Metals discovers higher grade and Sosandar raises cash

1

URU Metals (LON: URU) shares are higher on news about 74.28% owned Zeb Nickel Corp that was released yesterday afternoon. Analysis of drilling shows a higher grade nickel mineralised zone below the historical resource. Deeper drilling should increase the resources grade. There will also be infill drilling on the gold discovery. The share price is one-third higher at 200p.

There was a small rise in the share price of clinical communications technology developer Feedback (LON: FDBK) on Tuesday when it reported its interim results, but today it has jumped 19.1% to 146.5p. Progress has been slow but there are signs that it could accelerate. The £450,000 contract with a Sussex community diagnostic centre is up for renewal and should be worth much more when it is renewed. Other NHS trusts are showing interest in the company’s services. There was cash of £9.23m at the end of November 2022, so Feedback can finance further development and cover losses.

Deltic Energy (LON: DELT) says that there is a 300bcf gas discovery on Shell-operated Pensacola well in the southern North Sea, where it has a 30% working interest. Management will decide whether to fund further development or sell the interest. The share price rose 16.7% to 3.15p.

Training and software services provider Pennant International (LON: PEN) confirmed that it was profitable in 2022 even though revenues declined. Gross margins improved because software revenues are a greater proportion of revenues. Net debt has fallen to £400,000 and there should be net cash by the end of 2023. The order book is worth £25m.The share price recovered by 14% to 32.5p.

Chain and transmission equipment supplier Renold (LON: RNO) has sparked an upgrade with its latest trading statement. In the 10 months to January 2023 trading has continued to be strong. Sales growth was 17%. Even excluding the major military contract, order intake was more than one-fifth higher. The 2022-23 earnings forecast has been raised by 6% to 4.8p a share. The share price moved up by 10.4% to 27.05p.

Online fashion retailer Sosandar (LON: SOS) is raising £4m at 22p a share and up to £500,000 more from a retail offer. The retail offer closes on 16 February. The share price slipped by 12.9% to 23p. This cash will finance higher stock levels for third parties, including Sainsbury, and further investment in building up the customer base.

A placing by kidney diagnostics developer Renalytix (LON: RENX) has generated £16.9m at 90p a share or $2.17 for an American Depositary Share, which represents two shares. The majority of the cash will be used for clinical product development and marketing. The share price fell 10.2% to 110p.

Laundry technology developer Xeros Technology (LON: XSG) will report a higher than expected loss for 2022. This is due to the timing of milestone payments and restructuring costs. Cash is lower than forecast at £6.5m. Cash burn should reduce from £500,000/month this year. finnCap still assumes that Xeros Technology can become profitable in 2025. The share price declined by 7.14% to 4.55p.

Barratt Developments, BP, and Deltic Energy with Alan Green

The UK Investor Magazine was delighted to be joined by Alan Green for our weekly instalment of UK equities and discussion around key market themes.

Register for UK Investor Magazine Virtual Investor Conference

We discuss:

  • Barratt Developments (LON:BDEV)
  • BP (LON:BP)
  • Deltic Energy (LON:DLT)
  • ECR Minerals (LON:ECR)

We start by looking at the UK economy and a Think Tank prediction a UK recession will now be avoided. The FTSE 100 has reached new all-time highs above 7,900 – we look at the future trajectory for London’s leading index. We also the FTSE 250 and AIM, and the correlation with certain UK economic data points.

After a torrid year for Barratt Developments shares in 2022, there was reason for optimism in this morning results after the homebuilder said they were encouraged by January sales figures. We delve into the numbers.

BP confirmed bumper earnings for 2022 yesterday, as expected. We look at Barclay’s £10 price target and run through their key metrics.

We finish with a look at Deltic Energy and ECR Minerals.

Renold – record order book running faster than sales

The industrial chains and related power transmission products group Renold (LON:RNO) has issued a very positive Trading Update, it is noting record order books and is now expecting to beat market profit forecastsfor the year.

The group, which is a global leader in the manufacture of industrial chains, is also a manufacturer of a range of torque transmission products. 

Its products, which are sold throughout the world to a broad range of original equipment manufacturers and distributors, are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

For the ten months to the end of January 2023 the group’s order intake was £216.5m, some 19.2% better, leaving the current order book at a record £104.1m.

Its order intake is running far ahead of its sales, with its turnover for the first ten months of the current year to end March, showing a 25.4% growth at £199.0m.

In excess of market expectations

The group stated that given the continued sales growth, a strong orderbook, benefits of the cost reduction and efficiency programmes, and the successful recovery of cost inflation on raw material and energy, the company is confident the current trading momentum will deliver revenues and underlying operating profit for the full year in excess of market expectations.

Analyst Opinion – Target Price of 52p

David Buxton at brokers finnCap has estimated that the current year to end March will see revenues lift to £238.3m (£195.2m) generating adjusted pre-tax profits of £14.3m (£11.5m) and taking earnings up to 4.8p (4.0p) per share.

For the coming year he has pencilled in £233.8m sales, £13.9m profits and 4.6p of earnings.

Anticipating a rerating for the group’s shares over the next two years he has a 52p Target Price out on the shares.

Conclusion – a very healthy upside on 5.4 pe

This group’s shares are currently on a very low rating, trading at 24.5p which puts them on only a 5.4 times price-to-earnings ratio.

These shares offer a very healthy upside.